Friday, January 8, 2010, 7:30PM AEST - The Australian Stockmarket is closed.
To create a watchlist or portfolio of shares, Register

Merck & Co. Inc. (MRK)

 8:00AM AEST: 37.72 USD   0.00 (0.00%)  
 MORE ON MRK 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 MERCK CO INC (NYSE:MRK) Delayed quote dataEdit
Last Trade:37.72 USD
Trade Time: 8:00AM AEST
Change: 0.00 (0.00%)
Prev Close:37.72
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:40.12
Day's Range:N/A - N/A
52wk Range:20.05 - 38.42
Volume:0
Avg Vol (3m):19,071,400
Market Cap:79.56B
P/E (ttm):9.91
EPS (ttm):3.81
Div & Yield:1.52 (4.03%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add MRK to Portfolio   Download Data

 HEADLINES 
•China's Vaccine Sector: How to Get in the Game
at Seeking Alpha (Fri 7:00PM)
•A Little Bit More On the Job Cuts at Merck & Pfizer
at The Wall Street Journal Online (Fri 9:32AM)
•Pfizer Strides Farther Into Generics
at Motley Fool (Fri 7:24AM)
•AstraZeneca makes deal with generic challenger
AP (Fri 7:10AM)
•Biotech 2010 Winners
TheStreet.com TV (Fri 1:56AM)
•Merck to Hold Fourth-Quarter 2009 Sales and Earnings Conference Call on Feb. 16
Business Wire (Fri 12:30AM)
•Good Stocks to Buy Now
at Motley Fool (Thu 11:00PM)
•UPDATE - AstraZeneca sees off Nexium threat with Teva deal
at Reuters (Thu 8:32PM)
•What Merck's CEO Said Today About Possible Job Cuts
at The Wall Street Journal Online (Thu 7:44AM)
•Can a Japanese Cloth Company Make Drugs? FDA Says Yes
at The Wall Street Journal Online (Thu 6:29AM)
•[video] Biotech 2010 Winners
at TheStreet.com (Thu 4:44AM)
•Pfizer, Like Much of Big Pharma, Pushes Further Into Generics
at The Wall Street Journal Online (Thu 3:49AM)
•Stocks Up, Dollar Down On Mixed Services, Employment Data
at Barrons.com (Thu 3:22AM)
•The Crisis Is Over, Savor The Growth
at Forbes.com (Thu 2:30AM)
•Skadden takes top seat as legal dealmaker of 2009
at Reuters (Thu 1:20AM)
•Neutral on Santarus
Zacks.com (Thu 12:35AM)
•FDA drug approvals mostly flat in 2009
AP (Wed, Jan 6)
More Headlines for MRK...
 ANALYST 
EPS Est (next year) (Dec-09) :3.27
EPS Est (in 2 years) (Dec-10) :3.48
Avg Rec (current)*:2.1
PEG Ratio:2.52
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Merck & Co., Inc. provides products for human and animal health primarily in the United States. The company’s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices